This is also in concordance with a previous immunohistochemical study of 491 breast tumors where high expression of mesenchymal markers (i.e., vimentin, N-cadherin) and low expression of CDH1 were found almost exclusively in the triple-negative subgroup of tumors [45]. This evidence concerns the gene CDH2 and breast neoplasm.